Costs of opioid therapy for chronic nonmalignant pain in Germany: an economic model comparing transdermal fentanyl (Durogesic) with controlled-release morphine

By Radbruch Lukas   Lehmann K.   Gockel H.-H.   Neighbors D.   Nuyts G.  

The European Journal of Health Economics, Vol. 3, Iss. 2, 2002-06 ,pp. : 111-119

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules

By Nicholson Bruce   Ross Edgar   Weil Arnold   Sasaki John   Sacks Gerald  

Current Medical Research and Opinion, Vol. 22, Iss. 3, 2006-03 ,pp. : 539-550

Informa Healthcare

Access to resources Recommend Favorite

Patient and physician perceptions of treatment of moderate-to-severe chronic pain with oral opioids

By Duensing L.   Eksterowicz N.   Macario A.   Brown M.   Stern L.   Ogbonnaya A.  

Current Medical Research and Opinion, Vol. 26, Iss. 7, 2010-07 ,pp. : 1579-1585

Informa Healthcare

Access to resources Recommend Favorite

Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain

By Nicholson Bruce   Ross Edgar   Sasaki John   Weil Arnold  

Current Medical Research and Opinion, Vol. 22, Iss. 8, 2006-08 ,pp. : 1503-1514

Informa Healthcare

Access to resources Recommend Favorite

Comment and Reply on: Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain

By Crudele Nancy   Haddox J. David   Nicholson Bruce   Ross Edgar   Sasaki John   Weil Arnold  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1053-1056

Informa Healthcare

Access to resources Recommend Favorite